{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:11:10Z","timestamp":1776442270562,"version":"3.51.2"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007648","name":"Durban University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004695","name":"Inyuvesi Yakwazulu-Natali","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004695","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.prrv.2024.01.005","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T02:39:53Z","timestamp":1708137593000},"page":"44-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A Review Of Host-Specific Diagnostic And Surrogate Biomarkers In Children With Pulmonary Tuberculosis"],"prefix":"10.1016","volume":"52","author":[{"given":"Junaid","family":"Shaik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manormoney","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash","family":"Jeena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prrv.2024.01.005_b0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/heapol\/czx157","article-title":"Treatment of tuberculosis in complex emergencies in developing countries: a scoping review","volume":"33","author":"Munn-Mace","year":"2018","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.prrv.2024.01.005_b0010","doi-asserted-by":"crossref","first-page":"E159","DOI":"10.1016\/S2214-109X(21)00548-9","article-title":"What is the global burden of tuberculosis among children?","volume":"10","author":"Carvalho","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.prrv.2024.01.005_b0015","unstructured":"World Health Organization. Global Tuberculosis Report 2021. Available at: https:\/\/www.who.int\/tb\/publications\/global_report\/en\/. (Accessed 01 August 2022)."},{"key":"10.1016\/j.prrv.2024.01.005_b0020","doi-asserted-by":"crossref","first-page":"653898","DOI":"10.3389\/fimmu.2021.653898","article-title":"Discovery and validation of a three-cytokine plasma signature as a biomarker for diagnosis of pediatric tuberculosis","volume":"12","author":"Kumar","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.prrv.2024.01.005_b0025","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3389\/fimmu.2017.01059","article-title":"Age-stratified T cell responses in children infected with Mycobacterium tuberculosis","volume":"8","author":"Dreesman","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.prrv.2024.01.005_b0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2334-14-125","article-title":"Impact of HIV co-infection on plasma level of cytokines and chemokines of pulmonary tuberculosis patients","volume":"14","author":"Mihret","year":"2014","journal-title":"BMC infect Dis"},{"key":"10.1016\/j.prrv.2024.01.005_b0035","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4269\/ajtmh.17-0530","article-title":"The Impact of anti-retroviral therapy on tuberculosis detection at the national level in South Africa","volume":"99","author":"McLaren","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.prrv.2024.01.005_b0040","first-page":"264","article-title":"The role of interferon gamma release assay in the monitoring of response to anti-tuberculosis treatment in children","volume":"15","author":"Shaik","year":"2014","journal-title":"Paediatr Resp Rev"},{"key":"10.1016\/j.prrv.2024.01.005_b0045","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.3389\/fmicb.2019.02381","article-title":"Differential culturability of Mycobacterium tuberculosis in culture-negative sputum of patients with pulmonary tuberculosis and in a simulated model of dormancy","volume":"10","author":"Dusthackeer","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.prrv.2024.01.005_b0050","first-page":"35","article-title":"Diagnostic accuracy of the new Xpert MTB\/RIF Ultra for tuberculosis disease: A preliminary systematic review and meta-analysis","volume":"20","author":"Zhang","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.prrv.2024.01.005_b0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41598-023-27895-8","article-title":"Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity","volume":"13","author":"Sampath","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.prrv.2024.01.005_b0060","doi-asserted-by":"crossref","first-page":"a018515","DOI":"10.1101\/cshperspect.a018515","article-title":"Clinical immunology and multiplex biomarkers of human tuberculosis","volume":"5","author":"Walzl","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.prrv.2024.01.005_b0065","first-page":"2","article-title":"Cytokines and chemokines as biomarkers of tuberculosis","volume":"3","author":"Mihret","year":"2013","journal-title":"J Mycobac Dis"},{"key":"10.1016\/j.prrv.2024.01.005_b0070","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0272989X21994553","article-title":"Validity of surrogate endpoints and their impact on coverage recommendations: a retrospective analysis across international health technology assessment agencies","volume":"41","author":"Ciani","year":"2021","journal-title":"Med Decis Making"},{"key":"10.1016\/j.prrv.2024.01.005_b0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-0500-2-19","article-title":"MCP-3 and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay","volume":"2","author":"Ruhwald","year":"2009","journal-title":"BMC Research Notes"},{"key":"10.1016\/j.prrv.2024.01.005_b0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1473-3099(07)70112-3","article-title":"Biomarkers of treatment response in clinical trials of novel antituberculosis agents","volume":"7","author":"Perrin","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.prrv.2024.01.005_b0085","doi-asserted-by":"crossref","first-page":"594609","DOI":"10.3389\/fimmu.2020.594609","article-title":"Cytokine and chemokine signals of T-cell exclusion in tumors","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.prrv.2024.01.005_b0090","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.3390\/ijms21196979","article-title":"Pediatric tuberculosis: the Impact of \u201cOmics\u201d on diagnostics development","volume":"21","author":"Jakhar","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.prrv.2024.01.005_b0095","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.3389\/fmicb.2019.02789","article-title":"Immune biomarkers for diagnosis and treatment monitoring of tuberculosis: current developments and future prospects","volume":"10","author":"Yong","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.prrv.2024.01.005_b0100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/gene.2013.26","article-title":"Identification of biomarkers for Mycobacterium tuberculosis infection and disease in BCG-vaccinated young children in Southern India","volume":"14","author":"Dhanasekaran","year":"2013","journal-title":"Genes and Immun"},{"key":"10.1016\/j.prrv.2024.01.005_b0105","doi-asserted-by":"crossref","unstructured":"Mattos AMM, de S Almeida C, Franken KLMC, de S Alves CC, Abramo C, de Souza MA, et al. Increased IgG1, IFN-\u03b3, TNF-\u03b1 and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy. Int Immunol 2010; 22: 775\u201382. https:\/\/doi:10.1093\/intimm\/dxq429.","DOI":"10.1093\/intimm\/dxq429"},{"key":"10.1016\/j.prrv.2024.01.005_b0110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jinf.2014.10.019","article-title":"Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects","volume":"70","author":"Hur","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.prrv.2024.01.005_b0115","doi-asserted-by":"crossref","first-page":"640916","DOI":"10.3389\/fimmu.2021.640916","article-title":"Local pulmonary immunological biomarkers in tuberculosis","volume":"12","author":"Morrison","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.prrv.2024.01.005_b0120","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.prrv.2024.01.005_b0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tube.2017.08.004","article-title":"Host blood RNA signatures predict the outcome of tuberculosis treatment","volume":"107","author":"Thompson","year":"2017","journal-title":"Tuberculosis."},{"key":"10.1016\/j.prrv.2024.01.005_b0130","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1164\/rccm.201711-2340OC","article-title":"Four-gene pan-African blood signature predicts progression to tuberculosis","volume":"197","author":"Suliman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2024.01.005_b0135","doi-asserted-by":"crossref","first-page":"104173","DOI":"10.1016\/j.ebiom.2022.104173","article-title":"Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment","volume":"82","author":"Van Doorn","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.prrv.2024.01.005_b0140","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/tpj.13014","article-title":"Genomic limitations to RNA sequencing expression profiling","volume":"84","author":"Hirsch","year":"2015","journal-title":"Plant J"},{"key":"10.1016\/j.prrv.2024.01.005_b0145","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.jid.2016.06.003","article-title":"Research techniques made simple: Methodology and clinical applications of RNA sequencing","volume":"136","author":"Whitley","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.prrv.2024.01.005_b0150","doi-asserted-by":"crossref","unstructured":"Whittaker E, Gordon A, Kampmann B. 2008. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFN gamma? PLoS One 2008; 3: https:\/\/doi:10.1371\/journal.pone.0003901.3901.","DOI":"10.1371\/journal.pone.0003901"},{"issue":"69","key":"10.1016\/j.prrv.2024.01.005_b0155","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jinf.2014.06.013","article-title":"IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children","volume":"2014","author":"Latorre","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.prrv.2024.01.005_b0160","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1128\/CVI.05037-11","article-title":"Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with active tuberculosis","volume":"8","author":"Bertholet","year":"2011","journal-title":"Clin Vacc Immunol"},{"key":"10.1016\/j.prrv.2024.01.005_b0165","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.4049\/jimmunol.162.8.4928","article-title":"Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils","volume":"162","author":"Gasperini","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.prrv.2024.01.005_b0170","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/00365548.2011.632644","article-title":"Interferon-gamma inducible protein 10 as a biomarker of active tuberculosis and latent tuberculosis infection in children: a case-control study","volume":"44","author":"Alsleben","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.prrv.2024.01.005_b0175","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jinf.2013.08.005","article-title":"Cytokine responses to quantiferon peptides in pediatric tuberculosis: A pilot study","volume":"68","author":"Armand","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.prrv.2024.01.005_b0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1164\/rccm.201501-0059OC","article-title":"Mycobacteria-specific cytokine responses detect tuberculosis infection and distinguish latent from active tuberculosis","volume":"192","author":"Terbruegge","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2024.01.005_b0185","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5588\/ijtld.16.0351","article-title":"Multiple cytokines for the detection of Mycobacterium tuberculosis infection in children with tuberculosis","volume":"21","author":"Nausch","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.prrv.2024.01.005_b0190","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/pathogens10050517","article-title":"Cytokine biosignature of active and latent Mycobacterium tuberculosis infection in children","volume":"10","author":"Druszczynska","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.prrv.2024.01.005_b0195","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/cei.12396","article-title":"Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection","volume":"178","author":"Jenabian","year":"2014","journal-title":"Clin. Exp. Immunol"},{"key":"10.1016\/j.prrv.2024.01.005_b0200","doi-asserted-by":"crossref","first-page":"e64226","DOI":"10.1371\/journal.pone.0064226","article-title":"Utility of host markers detected in quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting","volume":"8","author":"Chegou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prrv.2024.01.005_b0205","doi-asserted-by":"crossref","unstructured":"Mariotti S, Teloni R, Iona E, Fattorini L, Romagnoli G, Gagliardi MC, et al. Mycobacterium tuberculosis diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells. Infect Immun 2004; 72: 4385\u201392. https:\/\/doi:10.1128\/IAI.72.8.4385-4392.2004. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002; 168: 3195\u2013204. https:\/\/doi:10.4049\/jimmunol.168.7.3195.","DOI":"10.4049\/jimmunol.168.7.3195"},{"key":"10.1016\/j.prrv.2024.01.005_b0210","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1164\/ajrccm.162.3.9911010","article-title":"Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis","volume":"162","author":"Matsuyama","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2024.01.005_b0215","doi-asserted-by":"crossref","first-page":"100102","DOI":"10.1016\/j.jctube.2019.100102","article-title":"Mycobacterium tuberculosis-specific cytokine biomarkers for the diagnosis of childhood TB in a TB-endemic setting","volume":"16","author":"Sudbury","year":"2019","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.prrv.2024.01.005_b0220","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cyto.2012.12.031","article-title":"Multiplex analysis of cytokines\/chemokines as biomarkers that differentiate healthy contacts from tuberculosis patients in high endemic settings","volume":"61","author":"Anbarasu","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.prrv.2024.01.005_b0225","doi-asserted-by":"crossref","first-page":"18217","DOI":"10.1038\/s41598-019-54803-w","article-title":"Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis","volume":"9","author":"Kumar","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.prrv.2024.01.005_b0230","doi-asserted-by":"crossref","first-page":"102909","DOI":"10.1016\/j.ebiom.2020.102909","article-title":"A three-marker protein biosignature distinguishes tuberculosis from other respiratory diseases in Gambian children","volume":"58","author":"Togun","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.prrv.2024.01.005_b0235","doi-asserted-by":"crossref","first-page":"653898","DOI":"10.3389\/fimmu.2021.653898","article-title":"Discovery and validation of a three-cytokine plasma signature as a biomarker for diagnosis of pediatric tuberculosis","volume":"12","author":"Kumar","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.prrv.2024.01.005_b0240","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1186\/s12879-021-06749-6","article-title":"Plasma chemokines as immune biomarkers for diagnosis of pediatric tuberculosis","volume":"21","author":"Kumar","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.prrv.2024.01.005_b0245","doi-asserted-by":"crossref","first-page":"641065","DOI":"10.3389\/fimmu.2021.641065","article-title":"Effect of inflammatory cytokines\/chemokines on pulmonary tuberculosis culture conversion and disease severity in HIV-infected and -uninfected individuals from South Africa","volume":"12","author":"Rambaran","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.prrv.2024.01.005_b0250","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/CVI.05366-11","article-title":"Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children","volume":"18","author":"Kumar","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.prrv.2024.01.005_b0255","doi-asserted-by":"crossref","unstructured":"Lundtoft C, Awuah AA-A, Nausch N, Enimil A, Mayatepek M, Owusu-Dabo E, et al. Alternative Quantiferon cytokines for diagnosis of children with active tuberculosis and HIV co-infection in Ghana. Med Microbiol Immunol 2017; 206: 259\u201365. https:\/\/doi: 10.1007\/s00430-017-0501-6.","DOI":"10.1007\/s00430-017-0501-6"},{"key":"10.1016\/j.prrv.2024.01.005_b0260","doi-asserted-by":"crossref","first-page":"e0118654","DOI":"10.1371\/journal.pone.0118654","article-title":"Co-infection with Mycobacterium tuberculosis impairs HIV-specific CD8+ and CD4+ T Cell functionality","volume":"10","author":"Chetty","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prrv.2024.01.005_b0265","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAD.0b013e328334895e","article-title":"Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients","volume":"24","author":"Kabeer","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.prrv.2024.01.005_b0270","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0264-410X(98)00124-8","article-title":"The effect of heterologous immunity upon the apparent efficacy of (e.g. BCG) vaccines","volume":"16","author":"Fine","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.prrv.2024.01.005_b0275","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1473-3099(07)70108-1","article-title":"Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development","volume":"7","author":"Gagneux","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.prrv.2024.01.005_b0280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tube.2018.08.011","article-title":"Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting","volume":"114","author":"Clifford","year":"2019","journal-title":"Tuberculosis"},{"key":"10.1016\/j.prrv.2024.01.005_b0285","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.tube.2011.01.001","article-title":"A multicenter evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis","volume":"91","author":"Ruhwald","year":"2011","journal-title":"Tuberculosis"},{"key":"10.1016\/j.prrv.2024.01.005_b0290","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.icb.7100027","article-title":"Life and death in the granuloma: immunopathology of tuberculosis","volume":"85","author":"Saunders","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.prrv.2024.01.005_b0295","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1183\/09031936.00055508","article-title":"Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis","volume":"32","author":"Ruhwald","year":"2008","journal-title":"Eur Resp J"},{"key":"10.1016\/j.prrv.2024.01.005_b0300","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1473-3099(13)70034-3","article-title":"Tuberculosis biomarkers discovery: developments, needs and challenges","volume":"13","author":"Wallis","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.prrv.2024.01.005_b0305","doi-asserted-by":"crossref","first-page":"011","DOI":"10.1186\/1753-6561-4-S3-O11","article-title":"The child\u2019s immune system and pediatric tuberculosis","volume":"4","author":"Bellanti","year":"2010","journal-title":"BMC Proceedings"},{"key":"10.1016\/j.prrv.2024.01.005_b0310","doi-asserted-by":"crossref","first-page":"e20606","DOI":"10.1371\/journal.pone.0020606","article-title":"A molecular assay for sensitive detection of pathogen-specific T-cells","volume":"6","author":"Kasprowicz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.prrv.2024.01.005_b0315","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/jcm9010111","article-title":"Point-of-care urine LAM tests for tuberculosis diagnosis: A status update","volume":"9","author":"Bulterys","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.prrv.2024.01.005_b0320","doi-asserted-by":"crossref","first-page":"2003492","DOI":"10.1183\/13993003.03492-2020","article-title":"Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomics model","volume":"58","author":"Heyckendorf","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2024.01.005_b0325","first-page":"e60460","article-title":"A tuberculosis molecular bacterial load assay (TB-MBLA)","volume":"158","author":"Sabiiti","year":"2020","journal-title":"J Vis Exp"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054224000186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054224000186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T15:07:10Z","timestamp":1734016030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054224000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":65,"alternative-id":["S1526054224000186"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2024.01.005","relation":{},"ISSN":["1526-0542"],"issn-type":[{"value":"1526-0542","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Review Of Host-Specific Diagnostic And Surrogate Biomarkers In Children With Pulmonary Tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2024.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}